Healthcare Equipment and Supplies
Company Overview of Ipsogen, Inc.
Ipsogen, Inc. develops diagnostic tools for the molecular diagnosis of leukemia, lymphomas, and breast cancer. Ipsogen, Inc. provides optimization of discovery and development of anti-cancer drugs. The company was founded in 2005 and is based in New Haven, Connecticut. As of January 1, 2013, Ipsogen, Inc. operates as a subsidiary of QIAGEN, Inc.
300 George Street
New Haven, CT 06511
Founded in 2005
Key Executives for Ipsogen, Inc.
Ipsogen, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Ipsogen, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.